编织型镍钛支架与药物洗脱支架治疗股腘动脉病变的比较
本研究回顾性比较了编织型镍钛支架(INS,Supera)与药物洗脱支架(DES,Zilver PTx)在股腘动脉病变初次介入治疗中的效果。主要终点为12个月内临床驱动的靶病变血运重建(CD-TLR),两组累积发生率分别为13%和18%,无显著差异(HR 1.36,95%CI 0.56-3.31)。结论认为两种支架在CD-TLR方面结果相当,无法偏好其中一种。
要点
- INS与DES在12个月CD-TLR累积发生率上无显著差异(13% vs 18%,HR 1.36,95%CI 0.56-3.31)。
- 敏感性分析中交互作用消失,整体结果不支持任一支架优于另一种。
核心结论
- 两种支架(INS和DES)在股腘动脉病变的CD-TLR方面结果相当,无法偏好其中一种,即使对于钙化或腘动脉病变也是如此。
研究设计与样本
- 回顾性比较研究,比较INS(Supera)与DES(Zilver PTx)在股腘动脉病变初次介入治疗中的效果。
- 采用逆概率治疗加权(IPTW)Cox模型,并进行倾向性评分匹配和协变量调整作为敏感性分析。
主要发现
- 12个月CD-TLR累积发生率:INS组13%,DES组18%(HR 1.36,95%CI 0.56-3.31)。
- 腘动脉病变治疗中支架效果无差异(HR 0.80,95%CI 0.21-3.13)。
- 敏感性分析中,调整后(HR 1.16,95%CI 0.51-2.62)和匹配分析(HR 1.35,95%CI 0.50-3.62)证实主要疗效结果。
- 交互作用在调整后(HR 0.28,95%CI 0.06-1.19)和匹配分析(HR 0.53,95%CI 0.10-2.91)中消失。
临床怎么用
- 对于股腘动脉病变的初次介入治疗,INS和DES均可选择,无需基于支架类型偏好一种。
- 钙化程度可能影响支架选择,但敏感性分析中交互作用不稳健,需个体化决策。
局限性
- 回顾性分析,尽管采用IPTW和敏感性分析,仍可能存在未测量混杂。
- 交互作用在敏感性分析中不显著,提示钙化亚组结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Information on performance of different stent platforms in endovascular revascularisation of femoropopliteal lesions is controversial and scarce. METHODS: Interwoven nitinol (INS, Supera) were compared with drug eluting (DES, Zilver PTx) stents with primary intervention for femoropopliteal lesions. The primary endpoint was time to clinically driven target lesion revascularisation (CD-TLR) within 12 months. Secondary endpoints were time to death, amputation and composite of death, amputation and CD-TLR. Due to the retrospective analysis, inverse probability treatment weighted (IPTW) Cox models were calculated to reach more similar patient populations with weights for the average treatment effect of the population. The two sensitivity analyses were propensity score matching and adjustment for covariates. RESULTS: At 12 months, the cumulative incidence of CD-TLR in the INS group (13%) and DES group (18%) did not differ (HR 1.36, 95% CI 0.56-3.31). A significant interaction between stents used and grade of calcification was observed (p = .006). HR for CD-TLR was 6.4 (95% CI 1.3-32.5) in none to mildly calcified favouring INS, and 0.3 (95% CI 0.1-1.3) for moderate to severely calcified lesions favouring DES. Stent efficiency did not differ comparing treatment of popliteal lesions (HR 0.80; 95% CI 0.21-3.13). Sensitivity analyses confirmed the primary efficacy outcome for either adjusted (HR 1.16; 95% CI 0.51-2.62) or matched analysis (HR 1.35; 95% CI 0.50-3.62)). Interaction of stents with calcification grade was lost for adjusted (HR 0.28; 95% CI 0.06-1.19) and matched analysis (HR 0.53; 95% CI 0.10-2.91). CONCLUSION: Both stents (INS and DES) showed comparable results regarding CD-TLR in femoropopliteal lesions, so that one stent could not be favoured over the other, even for calcified or popliteal artery lesions.
引用
- Haine A, Schmid MJ, Schindewolf M, et al. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease. Eur J Vasc Endovasc Surg. 2019. PMID: 31668949. doi:10.1016/j.ejvs.2019.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。